Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody
Volume: 39, Pages: 101907 - 101907
Published: Apr 1, 2020
Abstract
Neuromyelitis optica spectrum disorders (NMOSD) are a group of inflammatory central nervous system disorders characterized by optic neuritis, transverse myelitis, and anti-aquaporin 4 (AQP4) antibody production. However, it has recently been shown that some cases of typical NMOSD can be anti-AQP4 antibody-negative as well. In this study, we retrospectively investigated the disorder relapse-suppressing effect of tacrolimus (TAC) when combined...
Paper Details
Title
Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody
Published Date
Apr 1, 2020
Volume
39
Pages
101907 - 101907
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History